Latest Period
Q4 2025
Security Snapshot
ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) Institutional Ownership
CUSIP: 004468500
13F Institutional Holders and Ownership History from Q3 2020 to Q1 2026
Institutions Reporting
77
Shares (Excl. Options)
23,239,545
Price
$4.97
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- ACHV on Nasdaq
- Shares outstanding
- 107,480,651
- Price per share
- $3.58
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 23,239,545
- Total reported value
- $115,291,318
- % of total 13F portfolios
- 0%
- Share change
- +7,083,476
- Value change
- +$36,552,641
- Number of holders
- 77
- Price from insider filings
- $3.58
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share is tracked under CUSIP 004468500.
- 77 institutions reported positions in Q4 2025.
- 10 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 77 to 15 between Q4 2025 and Q1 2026.
- Reported value moved from $115,291,318 to $7,752,261.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 77 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 004468500?
CUSIP 004468500 identifies ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 004468500:
Significant Owners of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TPG GP A, LLC | 13% | $40,440,170 | 13,755,160 | TPG GP A, LLC | 17 Apr 2025 | |||
| venBio Global Strategic Fund V, L.P. | 10% | $31,567,712 | 10,737,317 | venBio Global Strategic Fund V, L.P. | 15 Apr 2026 | |||
| Paradigm Biocapital Advisors LP | 9.2% | $29,116,913 | 9,903,712 | Paradigm BioCapital Advisors LP | 17 Apr 2026 | |||
| Frazier Life Sciences Public Fund, L.P. | 6.5% | $19,479,817 | 6,625,788 | Frazier Life Sciences Public Fund, L.P. | 17 Apr 2026 | |||
| FRANKLIN RESOURCES INC | 12% | -28% | $31,654,889 | -$11,286,105 | 6,369,193 | -26% | Franklin Resources, Inc. | 31 Dec 2025 |
| Venrock Healthcare Capital Partners III, L.P. | 5.2% | $16,176,068 | 5,502,064 | Venrock Healthcare Capital Partners III, L.P. | 17 Apr 2026 | |||
| Alyeska Investment Group, L.P. | 5.6% | -43% | $9,395,574 | -$6,098,715 | 2,982,722 | -39% | Alyeska Investment Group, L.P. | 30 Sep 2025 |
| Contrarian Alpha, LP | 4.9% | $7,964,388 | 2,528,377 | Parker Quillen | 30 Sep 2025 | |||
| VANGUARD GROUP INC | 5% | $4,086,493 | 1,717,014 | The Vanguard Group | 31 Mar 2025 | |||
| BlackRock, Inc. | 0.6% | $711,220 | 314,699 | BlackRock, Inc. | 30 Jun 2025 |
As of 31 Dec 2025, 77 institutional investors reported holding 23,239,545 shares of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV). This represents 22% of the company’s total 107,480,651 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) together control 20% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC | 4.1% | 4,369,193 | +18747% | 0.01% | $21,714,889 |
| Propel Bio Management, LLC | 3.5% | 3,786,425 | 0% | 16% | $18,818,532 |
| VANGUARD GROUP INC | 2.3% | 2,474,312 | +0.51% | 0% | $12,297,331 |
| MILLENNIUM MANAGEMENT LLC | 1.3% | 1,359,116 | +472% | 0% | $6,754,807 |
| Simplify Asset Management Inc. | 1.1% | 1,184,512 | 0% | 0.1% | $5,887,025 |
| MARSHALL WACE, LLP | 0.95% | 1,019,281 | +32% | 0% | $5,065,825 |
| TWO SIGMA INVESTMENTS, LP | 0.7% | 748,616 | +71% | 0.01% | $3,720,622 |
| Nantahala Capital Management, LLC | 0.6% | 648,885 | 0% | 0.19% | $3,224,958 |
| LPL Financial LLC | 0.59% | 633,148 | +91% | 0% | $3,146,746 |
| RAYMOND JAMES FINANCIAL INC | 0.56% | 599,679 | +31% | 0% | $2,980,404 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.56% | 599,611 | +18% | 0% | $2,981,591 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.46% | 496,350 | +35% | 0% | $2,466,859 |
| KVP Capital Advisors, LP | 0.43% | 462,355 | 0% | 2.4% | $2,297,904 |
| GOLDMAN SACHS GROUP INC | 0.42% | 450,928 | +101% | 0% | $2,241,112 |
| BlackRock, Inc. | 0.39% | 419,133 | +7.1% | 0% | $2,083,091 |
| Pathstone Holdings, LLC | 0.39% | 416,667 | -17% | 0.01% | $1,858,335 |
| JANE STREET GROUP, LLC | 0.36% | 382,211 | 0% | $1,899,588 | |
| UBS Group AG | 0.27% | 285,229 | +260% | 0% | $1,417,588 |
| Shay Capital LLC | 0.22% | 234,937 | -19% | 0.19% | $1,167,637 |
| STATE STREET CORP | 0.22% | 234,257 | +6.3% | 0% | $1,164,257 |
| NORTHERN TRUST CORP | 0.21% | 229,879 | +4.8% | 0% | $1,142,499 |
| 683 Capital Management, LLC | 0.2% | 214,897 | 0.09% | $1,068,038 | |
| TWO SIGMA ADVISERS, LP | 0.2% | 209,900 | +90% | 0% | $1,043,203 |
| BNP PARIBAS FINANCIAL MARKETS | 0.16% | 167,945 | 0% | 0% | $834,687 |
| Squarepoint Ops LLC | 0.15% | 164,605 | -56% | 0% | $818,087 |
Institutional Holders of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 2,623,820 | $7,752,261 | +$769,629 | $2.94 | 15 |
| 2025 Q4 | 23,239,545 | $115,291,318 | +$36,552,641 | $4.97 | 77 |
| 2025 Q3 | 15,541,415 | $48,917,159 | -$26,338,868 | $3.15 | 65 |
| 2025 Q2 | 26,238,674 | $59,299,106 | +$26,395,211 | $2.26 | 64 |
| 2025 Q1 | 14,388,656 | $38,412,610 | -$6,420,566 | $2.67 | 72 |
| 2024 Q4 | 16,340,748 | $57,510,675 | -$2,280,524 | $3.52 | 70 |
| 2024 Q3 | 16,929,998 | $81,217,159 | +$2,394,591 | $4.74 | 64 |
| 2024 Q2 | 12,513,128 | $58,811,518 | +$9,414,756 | $4.70 | 54 |
| 2024 Q1 | 10,495,260 | $47,701,835 | +$35,368,247 | $4.54 | 39 |
| 2023 Q4 | 2,727,493 | $11,236,940 | -$1,729,113 | $4.12 | 29 |
| 2023 Q3 | 3,117,219 | $13,403,691 | -$2,279,792 | $4.30 | 35 |
| 2023 Q2 | 3,562,232 | $18,487,663 | +$5,645,131 | $5.19 | 38 |
| 2023 Q1 | 2,470,554 | $16,600,668 | +$3,392,110 | $6.80 | 31 |
| 2022 Q4 | 1,999,698 | $4,902,826 | -$458,841 | $2.45 | 27 |
| 2022 Q3 | 2,121,733 | $7,001,230 | +$176,107 | $3.30 | 28 |
| 2022 Q2 | 2,043,015 | $9,968,000 | -$109,417 | $4.88 | 31 |
| 2022 Q1 | 1,932,821 | $14,633,000 | -$2,149 | $7.57 | 33 |
| 2021 Q4 | 1,918,795 | $14,925,000 | +$535,636 | $7.78 | 26 |
| 2021 Q3 | 1,782,658 | $15,149,000 | -$1,185,059 | $8.50 | 30 |
| 2021 Q2 | 1,948,272 | $17,498,000 | +$7,592,533 | $8.98 | 28 |
| 2021 Q1 | 1,007,113 | $11,662,000 | +$6,322,912 | $11.58 | 16 |
| 2020 Q4 | 493,003 | $3,994,000 | +$307,274 | $8.10 | 14 |
| 2020 Q3 | 452,590 | $3,789,000 | +$3,789,000 | $8.37 | 12 |